会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • EXPANDABLE MULTI-PORT THERAPEUTIC DELIVERY SYSTEM AND DEVICE
    • 可扩展的多端口治疗系统和设备
    • WO2006033777A1
    • 2006-03-30
    • PCT/US2005/030644
    • 2005-08-29
    • BOSTON SCIENTIFIC SCIMED, INC.MICKLEY, Timothy, J.PALASIS, MariaFREYMAN, Toby
    • MICKLEY, Timothy, J.PALASIS, MariaFREYMAN, Toby
    • A61M29/02A61M25/10
    • A61M25/104A61M25/10A61M2025/105A61M2025/1072
    • The present invention provides methods, systems, and devices that deliver therapeutic to the inner lumens, chambers, cavities, and vessels of the body. In one embodiment, a therapeutic delivery device for delivery of therapeutic to a target site within the body of a patient is provided. This device may include a catheter, an expandable multi-port housing fluidly coupled to the catheter and a sheath. The multi-port housing in this device may be sized to travel within a lumen of a patient and may be adapted to expand from a first configuration to a second configuration. The multi-port housing may also contain at least two ejection ports coupled to an internal lumen of the multi-port housing. In some embodiments the multi-port housing is a bladder, while in others it is a frame or a group of outwardly extending arms. In each case, the device is configured to deliver therapeutic to a remote site in the body of a patient.
    • 本发明提供了将治疗剂递送到身体的内腔,腔室,空腔和血管的方法,系统和装置。 在一个实施例中,提供了用于将治疗剂递送到患者体内的靶部位的治疗递送装置。 该装置可以包括导管,可流体地联接到导管的可扩展多端口壳体和护套。 该装置中的多端口壳体的尺寸可以设计成在患者的内腔内行进,并且可以适于从第一构型扩展到第二构造。 多端口壳体还可以包含联接到多端口壳体的内腔的至少两个喷射端口。 在一些实施例中,多端口壳体是膀胱,而在另一些实施例中,其是框架或一组向外延伸的臂。 在每种情况下,该装置被配置为将治疗剂递送到患者体内的远端位置。
    • 5. 发明申请
    • ROTATABLE MULTI-PORT THERAPEUTIC DELIVERY DEVICE
    • 可旋转的多端口治疗设备
    • WO2006107408A1
    • 2006-10-12
    • PCT/US2006/005009
    • 2006-02-14
    • BOSTON SCIENTIFIC SCIMED, INC.NAIMARK, WendyPALASIS, MariaFREYMAN, TobySHAW, William, J.
    • NAIMARK, WendyPALASIS, MariaFREYMAN, TobySHAW, William, J.
    • A61M25/00
    • A61M25/0069
    • The present invention relates to the delivery of therapeutic to a target area. More particularly, the present invention relates to therapeutic delivery devices, with, one or more therapeutic delivery bodies that have new and unique degrees of freedom of motion. A therapeutic delivery device (100, 300, 700, 900, 1200, 1300, 1800) according to the invention comprises a steerable elongated member (310, 710, 910, 1210, 1310, 1810) sized for insertion into a body of a patient; and a rotatable therapeutic delivery body (320, 720, 920, 1220, 1320, 1815) rotatably supported by the elongated member; the delivery body free to rotate about at least one axis of rotation, the delivery body having one or more therapeutic delivery ports, the rotatable therapeutic delivery body sized for insertion into a body of a patient.
    • 本发明涉及将治疗剂递送至目标区域。 更具体地,本发明涉及具有一种或多种具有新的和独特的运动自由度的治疗递送体的治疗递送装置。 根据本发明的治疗性输送装置(100,300,700,900,1200,1300,1800)包括尺寸适于插入患者体内的可操纵细长构件(310,710,910,1210,1310,1810) ; 以及由所述细长构件可旋转地支撑的可旋转治疗递送体(320,720,920,1220,1320,1815) 所述递送体自由地围绕至少一个旋转轴线旋转,所述递送体具有一个或多个治疗递送口,所述可转动的治疗递送体的尺寸设置成插入到患者体内。
    • 9. 发明申请
    • LOCAL CONTROL OF INFLAMMATION
    • 炎症的局部控制
    • WO2007089976A2
    • 2007-08-09
    • PCT/US2007/060581
    • 2007-01-16
    • BOSTON SCIENTIFIC SCIMED, INC.FREYMAN, TobyNAIMARK, WendyPALASIS, Maria
    • FREYMAN, TobyNAIMARK, WendyPALASIS, Maria
    • A61F2/06
    • A61F2/02A61F2/0077A61F2/07A61F2230/008A61F2250/0039A61F2250/0067
    • A medical device includes a carrier and an agent. The agent is formulated to control inflammation of biological tissue, such as heart tissue, and is releasably coupled to the carrier. The carrier is configured to be disposed in operative proximity to the biological tissue to be treated by the agent. In one embodiment, the carrier is configured to release the agent or otherwise deliver the agent to the biological tissue, thus controlling inflammation of the tissue. Also, a method to improve healing of biological tissue includes placing a medical device proximate to the heart of a patient, where the medical device has a carrier and an agent configured to control inflammation, the agent is releasably coupled to the carrier. In one embodiment, the method includes causing the agent to be released from the carrier.
    • 医疗器械包括载体和药剂。 制剂用于控制诸如心脏组织的生物组织的炎症,并且可释放地联接到载体上。 载体被配置为设置在操作中接近要由药剂处理的生物组织。 在一个实施方案中,载体被配置为释放试剂或以其它方式将试剂递送到生物组织,从而控制组织的炎症。 而且,改善生物组织愈合的方法包括将医疗装置放置在患者的心脏附近,其中医疗装置具有载体和构造成控制炎症的药剂,药剂可释放地联接到载体上。 在一个实施例中,该方法包括使得试剂从载体释放。